MX2014013794A - Composiciones para solubilizar celulas y/o tejido. - Google Patents

Composiciones para solubilizar celulas y/o tejido.

Info

Publication number
MX2014013794A
MX2014013794A MX2014013794A MX2014013794A MX2014013794A MX 2014013794 A MX2014013794 A MX 2014013794A MX 2014013794 A MX2014013794 A MX 2014013794A MX 2014013794 A MX2014013794 A MX 2014013794A MX 2014013794 A MX2014013794 A MX 2014013794A
Authority
MX
Mexico
Prior art keywords
compositions
tissue
solubilizing
solubilizing cells
skin
Prior art date
Application number
MX2014013794A
Other languages
English (en)
Other versions
MX369625B (es
Inventor
Byeong Hee Hwang
Samir Mitragotri
Russell M Lebovitz
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX2014013794A publication Critical patent/MX2014013794A/es
Publication of MX369625B publication Critical patent/MX369625B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5428—Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic

Abstract

Se proporcionan composiciones solubilizantes. Las composiciones comprenden al menos un surfactante zwitteriónico y al menos un surfactante no iónico. En una modalidad, las composiciones pueden ser útiles para solubilizar y remodelar y/o extirpar tejido sobre o debajo de la piel de un paciente, de manera opcional junto con la aplicación de energía a un área de interés en la piel. En una modalidad, al menos un aflauto se puede recoger y analizar del tejido solubilizado.
MX2014013794A 2012-05-16 2012-05-16 Composiciones para solubilizar celulas y/o tejido. MX369625B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/038169 WO2013172832A1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Publications (2)

Publication Number Publication Date
MX2014013794A true MX2014013794A (es) 2015-04-08
MX369625B MX369625B (es) 2019-11-14

Family

ID=49584087

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013794A MX369625B (es) 2012-05-16 2012-05-16 Composiciones para solubilizar celulas y/o tejido.

Country Status (10)

Country Link
EP (2) EP3056559B1 (es)
JP (1) JP2015528691A (es)
KR (1) KR102099487B1 (es)
CN (1) CN104520418A (es)
AU (2) AU2012380348B2 (es)
BR (1) BR112014028239B1 (es)
CA (1) CA2873707A1 (es)
IN (1) IN2014MN02536A (es)
MX (1) MX369625B (es)
WO (1) WO2013172832A1 (es)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5358492A (en) * 1976-11-08 1978-05-26 Kao Corp Anti-foggig agent composition with lng lasting effect
US5639630A (en) * 1995-05-16 1997-06-17 Bayer Corporation Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes
AU4990797A (en) * 1996-10-24 1998-05-15 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
EP1801591B1 (en) * 1997-08-04 2016-12-28 Advanced Life Science Institute, Inc. Methods for detection or measurement of viruses
US6589173B1 (en) 2000-07-17 2003-07-08 The Regents Of The University Of California Ultrasound system for disease detection and patient treatment
FR2848848B1 (fr) * 2002-12-19 2005-01-28 Oreal Composition de lavage des matieres keratiniques a base de tensioactif amphotere et de peg modifie par un groupe hydrophobe
US7186522B2 (en) * 2003-03-31 2007-03-06 Cytyc Corporation Papanicolau staining process
EP1680223A4 (en) * 2003-08-01 2008-07-09 Fqubed Inc DEVICES AND METHOD FOR EVALUATING THE LOCKING PROPERTIES OF A MEMBRANE
CN1901935A (zh) * 2003-12-30 2007-01-24 惠氏公司 具有改进耐受性的免疫原组合物中的疏水性蛋白调配物
JP4422550B2 (ja) * 2004-05-25 2010-02-24 日華化学株式会社 親水性フッ素樹脂粒子の製造方法
WO2006026248A1 (en) * 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions and methods employing zwitterionic detergent combinations
US8389582B2 (en) * 2007-08-06 2013-03-05 Samir Mitragotri Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
WO2009048681A2 (en) * 2007-08-06 2009-04-16 The Regents Of The University Of California Methods of tissue-based diagnosis
EP3023107A1 (en) * 2008-04-21 2016-05-25 Nanobio Corporation Nanoemulsion influenza vaccine
CA2722445A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
US7700530B2 (en) * 2008-06-30 2010-04-20 Kimberly Clark Worldwide, Inc. Polysensorial personal care cleanser comprising a quaternary silicone surfactant
JP5382687B2 (ja) * 2008-11-12 2014-01-08 独立行政法人産業技術総合研究所 ルシフェリン−ルシフェラーゼ反応における発光強度の低下を抑制するための組成物及び方法
US20100226983A1 (en) * 2009-01-28 2010-09-09 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
CN102395881A (zh) * 2009-02-13 2012-03-28 加州大学评议会 基于组织的诊断的系统、方法和装置
US20120064136A1 (en) * 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions

Also Published As

Publication number Publication date
AU2012380348B2 (en) 2017-02-23
EP2756061A1 (en) 2014-07-23
MX369625B (es) 2019-11-14
AU2017203389A1 (en) 2017-06-08
JP2015528691A (ja) 2015-10-01
EP3056559A2 (en) 2016-08-17
IN2014MN02536A (es) 2015-09-04
CN104520418A (zh) 2015-04-15
CA2873707A1 (en) 2013-11-21
BR112014028239A2 (pt) 2017-06-27
EP2756061A4 (en) 2014-08-13
EP3056559B1 (en) 2019-07-10
KR20150023394A (ko) 2015-03-05
EP3056559A3 (en) 2016-10-12
AU2012380348A1 (en) 2015-01-22
WO2013172832A1 (en) 2013-11-21
BR112014028239B1 (pt) 2021-05-11
KR102099487B1 (ko) 2020-04-09

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
MX2014009256A (es) Dispositivos de recogida de muestras con agentes de estabilizacion sanguinea.
WO2012116081A3 (en) Methods for identifying cosmetic agents for skin care compositions
WO2013078402A3 (en) Tissue and stone removal device
WO2010027792A8 (en) Treatment of sweating and hyperhidrosis
MX342563B (es) Composiciones para el cuidado de la piel.
MX2013010343A (es) Composicion y metodos para el transplante de microbiota de colon.
FR2961087B1 (fr) Outil de prelevement d'un echantillon de tissu animal.
WO2013063418A3 (en) Devices and methods for performing knee arthroplasty
IN2013CN00091A (es)
WO2013166478A3 (en) Surgical instruments for oct assisted procedures
IL219318A0 (en) Pterostilbene (pter) for use in the prevention and/or treatment of skin diseases, damages or injures
EP3453723A3 (en) Anti-asic1 antibodies and uses thereof
GB201304564D0 (en) Novel removable clothing
WO2014053913A3 (en) Navigation instruments for subchondral bone treatment
MX2013011231A (es) Nanoparticulas basadas en lipidos.
MX2015015036A (es) Metodos para mejorar los perfiles de lipidos utilizando atrasentan.
EP3057535A4 (en) Bone grafts including osteogenic stem cells, and methods relating to the same
FR2979346B1 (fr) Nanocorps anti-vcam-1
MX2011011559A (es) Parasiticidas sanguineos.
MX369625B (es) Composiciones para solubilizar celulas y/o tejido.
EP2895089A4 (en) CUTTING BLOCK FOR DISTAL FEMUR AND METHOD FOR USE THEREOF
FR2982588B1 (fr) Panneau composite a ecope de prelevement integree
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
WO2014124059A3 (en) Inhibitors of hemeprotein-catalyzed lipid peroxidation

Legal Events

Date Code Title Description
FG Grant or registration